Cellerant Therapeutics Lands $2,094,341 New Financing
-
Feed Type
-
Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=13911eae-097f-4d16-8b6b-4e87f04f48ab&Preview=1 -
Date
9/24/2012 -
Company Name
Cellerant Therapeutics -
Mailing Address
1561 Industrial Road San Carlos, CA 94070 -
Company Description
Cellerant Therapeutics Inc. is a clinical-stage biotechnology company developing and commercializing the use of hematopoietic (blood-forming) stem cell-based therapies for the treatment of a variety of cancers and autoimmune diseases. -
Website
http://www.cellerant.com -
Transaction Type
Venture Equity -
Transaction Amount
$2,094,341 -
Transaction Round
Undisclosed -
Proceeds Purposes
Proceeds purposes were not disclosed. Includes conversion of $1,144,342 of principal and interest from convertible promissory notes. SEC regulatory filing. -
M&A Terms
-
Venture Investor
Undisclosed
